Clinical Trials Logo

Stage IIA Rectal Cancer AJCC v7 clinical trials

View clinical trials related to Stage IIA Rectal Cancer AJCC v7.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00745134 Terminated - Clinical trials for Recurrent Rectal Carcinoma

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

Start date: August 11, 2008
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well radiation therapy and capecitabine with or without curcumin before surgery works in treating patients with rectal cancer. Drugs such as curcumin may make tumor cells more sensitive to radiation therapy. Drugs used in chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving chemotherapy with radiation therapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. It is not yet known whether chemotherapy and radiation therapy is more effective with or without curcumin when given before surgery in patients with rectal cancer.